ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
QuantHealth raised $45 million in Series B funding led by Qumra Capital to scale AI-powered clinical trial simulations. The Tel Aviv company has simulated over 600 trials across 30 indications with up to 90% predictive accuracy, working with 12 of the world's top 20 pharmaceutical companies.
Tap to vote and see what everyone thinks.
Summary by ByteBrief